Artificial Organs and Bionic Implants Market in Spain 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	136 Pages	TechNavio	December, 2024	INF19462952

Best Price Guarantee
Price	from $2,500
Length	136 Pages
Publisher	TechNavio
Published Date	December, 2024
SKU	INF19462952

Artificial Organs And Bionic Implants Market In Spain 2024-2028

The artificial organs and bionic implants market in spain is forecasted to grow by USD 702.9 mn during 2023-2028, accelerating at a CAGR of 12.5% during the forecast period. The report on the artificial organs and bionic implants market in spain provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by scarcity of organ donors, increase in incidence of disabilities and organ failures, and technological advancements in country.

Technavio's artificial organs and bionic implants market in spain is segmented as below:

By Product

Artificial organs
Bionic implants

By End-user

Hospital and clinics
Specialty centers
Others

By Geographical Landscape

Europe

This study identifies the increase in medical tourism as one of the prime reasons driving the artificial organs and bionic implants market in spain growth during the next few years. Also, high number of road accidents leading to amputations and rising access to comprehensive medical care will lead to sizable demand in the market.

The report on the artificial organs and bionic implants market in spain covers the following areas:

Artificial Organs And Bionic Implants Market in Spain sizing
Artificial Organs And Bionic Implants Market in Spain forecast
Artificial Organs And Bionic Implants Market in Spain industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial organs and bionic implants market in spain vendors that include Asahi Kasei Corp., Baxter International Inc., Berlin Heart GmbH, Boston Scientific Corp., Edwards Lifesciences Corp., Ekso Bionics Holdings Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Medtronic Plc, Ossur hf, Ottobock SE and Co. KGaA, Sonova AG, Terumo Medical Corp., and Zimmer Biomet Holdings Inc.. Also, the artificial organs and bionic implants market in spain analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value Chain Analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2023; 4.4 Market outlook: Forecast for 2023-2028; Chart on Spain - Market size and forecast 2023-2028 ($ million); Data Table on Spain - Market size and forecast 2023-2028 ($ million); Chart on Spain: Year-over-year growth 2023-2028 (%); Data Table on Spain: Year-over-year growth 2023-2028 (%)
5 Historic Market Size: 5.1 Artificial Organs And Bionic Implants Market in Spain 2018 - 2022; Historic Market Size - Data Table on Artificial Organs And Bionic Implants Market in Spain 2018 - 2022 ($ million); 5.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 5.3 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Artificial Organs and Bionic Implants Market in Spain
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 7.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Artificial organs - Market size and forecast 2023-2028; Chart on Artificial organs - Market size and forecast 2023-2028 ($ million); Data Table on Artificial organs - Market size and forecast 2023-2028 ($ million); Chart on Artificial organs - Year-over-year growth 2023-2028 (%); Data Table on Artificial organs - Year-over-year growth 2023-2028 (%); 8.4 Bionic implants - Market size and forecast 2023-2028; Chart on Bionic implants - Market size and forecast 2023-2028 ($ million); Data Table on Bionic implants - Market size and forecast 2023-2028 ($ million); Chart on Bionic implants - Year-over-year growth 2023-2028 (%); Data Table on Bionic implants - Year-over-year growth 2023-2028 (%); 8.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by End-user: 9.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 9.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 9.3 Hospital and clinics - Market size and forecast 2023-2028; Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ million); Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ million); Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%); Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%); 9.4 Specialty centers - Market size and forecast 2023-2028; Chart on Specialty centers - Market size and forecast 2023-2028 ($ million); Data Table on Specialty centers - Market size and forecast 2023-2028 ($ million); Chart on Specialty centers - Year-over-year growth 2023-2028 (%); Data Table on Specialty centers - Year-over-year growth 2023-2028 (%); 9.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 9.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Drivers, Challenges, and Opportunity/Restraints: 11.1 Market drivers; 11.2 Market challenges; 11.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 11.4 Market opportunities/restraints
12 Competitive Landscape: 12.1 Overview; 12.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 12.3 Landscape disruption; Overview on factors of disruption; 12.4 Industry risks; Impact of key risks on business
13 Competitive Analysis: 13.1 Companies profiled; Companies covered; 13.2 Company ranking index; Company ranking index; 13.3 Market positioning of companies; Matrix on companies position and classification; 13.4 Asahi Kasei Corp.; Asahi Kasei Corp. - Overview; Asahi Kasei Corp. - Business segments; Asahi Kasei Corp. - Key news; Asahi Kasei Corp. - Key offerings; Asahi Kasei Corp. - Segment focus; SWOT; 13.5 Boston Scientific Corp.; Boston Scientific Corp. - Overview; Boston Scientific Corp. - Business segments; Boston Scientific Corp. - Key news; Boston Scientific Corp. - Key offerings; Boston Scientific Corp. - Segment focus; SWOT; 13.6 Edwards Lifesciences Corp.; Edwards Lifesciences Corp. - Overview; Edwards Lifesciences Corp. - Business segments; Edwards Lifesciences Corp. - Key news; Edwards Lifesciences Corp. - Key offerings; Edwards Lifesciences Corp. - Segment focus; SWOT; 13.7 Johnson and Johnson Inc.; Johnson and Johnson Inc. - Overview; Johnson and Johnson Inc. - Business segments; Johnson and Johnson Inc. - Key news; Johnson and Johnson Inc. - Key offerings; Johnson and Johnson Inc. - Segment focus; SWOT; 13.8 Medtronic Plc; Medtronic Plc - Overview; Medtronic Plc - Business segments; Medtronic Plc - Key news; Medtronic Plc - Key offerings; Medtronic Plc - Segment focus; SWOT; 13.9 Ossur hf; Ossur hf - Overview; Ossur hf - Business segments; Ossur hf - Key offerings; Ossur hf - Segment focus; SWOT; 13.10 Ottobock SE and Co. KGaA; Ottobock SE and Co. KGaA - Overview; Ottobock SE and Co. KGaA - Product / Service; Ottobock SE and Co. KGaA - Key offerings; SWOT; 13.11 Sonova AG; Sonova AG - Overview; Sonova AG - Business segments; Sonova AG - Key offerings; Sonova AG - Segment focus; SWOT; 13.12 Terumo Medical Corp.; Terumo Medical Corp. - Overview; Terumo Medical Corp. - Product / Service; Terumo Medical Corp. - Key offerings; SWOT; 13.13 Zimmer Biomet Holdings Inc.; Zimmer Biomet Holdings Inc. - Overview; Zimmer Biomet Holdings Inc. - Business segments; Zimmer Biomet Holdings Inc. - Key news; Zimmer Biomet Holdings Inc. - Key offerings; Zimmer Biomet Holdings Inc. - Segment focus; SWOT
14 Appendix: 14.1 Scope of the report; 14.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 14.3 Currency conversion rates for US$; Currency conversion rates for US$; 14.4 Research methodology; Research methodology; 14.5 Data procurement; Information sources; 14.6 Data validation; Data validation; 14.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 14.8 Data synthesis; Data synthesis; 14.9 360 degree market analysis; 360 degree market analysis; 14.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Product; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Company Market Positioning; Exhibits7: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits8: Overview on criticality of inputs and factors of differentiation; Exhibits9: Overview on factors of disruption; Exhibits10: Impact of drivers and challenges in 2023 and 2028; Exhibits11: Parent Market; Exhibits12: Data Table on - Parent Market; Exhibits13: Market characteristics analysis; Exhibits14: Value Chain Analysis; Exhibits15: Offerings of companies included in the market definition; Exhibits16: Market segments; Exhibits17: Chart on Spain - Market size and forecast 2023-2028 ($ million); Exhibits18: Data Table on Spain - Market size and forecast 2023-2028 ($ million); Exhibits19: Chart on Spain: Year-over-year growth 2023-2028 (%); Exhibits20: Data Table on Spain: Year-over-year growth 2023-2028 (%); Exhibits21: Historic Market Size - Data Table on Artificial Organs And Bionic Implants Market in Spain 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits24: Five forces analysis - Comparison between 2023 and 2028; Exhibits25: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits27: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits28: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits29: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits30: Chart on Market condition - Five forces 2023 and 2028; Exhibits31: Chart on Product - Market share 2023-2028 (%); Exhibits32: Data Table on Product - Market share 2023-2028 (%); Exhibits33: Chart on Comparison by Product; Exhibits34: Data Table on Comparison by Product; Exhibits35: Chart on Artificial organs - Market size and forecast 2023-2028 ($ million); Exhibits36: Data Table on Artificial organs - Market size and forecast 2023-2028 ($ million); Exhibits37: Chart on Artificial organs - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Artificial organs - Year-over-year growth 2023-2028 (%); Exhibits39: Chart on Bionic implants - Market size and forecast 2023-2028 ($ million); Exhibits40: Data Table on Bionic implants - Market size and forecast 2023-2028 ($ million); Exhibits41: Chart on Bionic implants - Year-over-year growth 2023-2028 (%); Exhibits42: Data Table on Bionic implants - Year-over-year growth 2023-2028 (%); Exhibits43: Market opportunity by Product ($ million); Exhibits44: Data Table on Market opportunity by Product ($ million); Exhibits45: Chart on End-user - Market share 2023-2028 (%); Exhibits46: Data Table on End-user - Market share 2023-2028 (%); Exhibits47: Chart on Comparison by End-user; Exhibits48: Data Table on Comparison by End-user; Exhibits49: Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on Specialty centers - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on Specialty centers - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on Specialty centers - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on Specialty centers - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits61: Market opportunity by End-user ($ million); Exhibits62: Data Table on Market opportunity by End-user ($ million); Exhibits63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits64: Impact of drivers and challenges in 2023 and 2028; Exhibits65: Overview on criticality of inputs and factors of differentiation; Exhibits66: Overview on factors of disruption; Exhibits67: Impact of key risks on business; Exhibits68: Companies covered; Exhibits69: Company ranking index; Exhibits70: Matrix on companies position and classification; Exhibits71: Asahi Kasei Corp. - Overview; Exhibits72: Asahi Kasei Corp. - Business segments; Exhibits73: Asahi Kasei Corp. - Key news; Exhibits74: Asahi Kasei Corp. - Key offerings; Exhibits75: Asahi Kasei Corp. - Segment focus; Exhibits76: SWOT; Exhibits77: Boston Scientific Corp. - Overview; Exhibits78: Boston Scientific Corp. - Business segments; Exhibits79: Boston Scientific Corp. - Key news; Exhibits80: Boston Scientific Corp. - Key offerings; Exhibits81: Boston Scientific Corp. - Segment focus; Exhibits82: SWOT; Exhibits83: Edwards Lifesciences Corp. - Overview; Exhibits84: Edwards Lifesciences Corp. - Business segments; Exhibits85: Edwards Lifesciences Corp. - Key news; Exhibits86: Edwards Lifesciences Corp. - Key offerings; Exhibits87: Edwards Lifesciences Corp. - Segment focus; Exhibits88: SWOT; Exhibits89: Johnson and Johnson Inc. - Overview; Exhibits90: Johnson and Johnson Inc. - Business segments; Exhibits91: Johnson and Johnson Inc. - Key news; Exhibits92: Johnson and Johnson Inc. - Key offerings; Exhibits93: Johnson and Johnson Inc. - Segment focus; Exhibits94: SWOT; Exhibits95: Medtronic Plc - Overview; Exhibits96: Medtronic Plc - Business segments; Exhibits97: Medtronic Plc - Key news; Exhibits98: Medtronic Plc - Key offerings; Exhibits99: Medtronic Plc - Segment focus; Exhibits100: SWOT; Exhibits101: Ossur hf - Overview; Exhibits102: Ossur hf - Business segments; Exhibits103: Ossur hf - Key offerings; Exhibits104: Ossur hf - Segment focus; Exhibits105: SWOT; Exhibits106: Ottobock SE and Co. KGaA - Overview; Exhibits107: Ottobock SE and Co. KGaA - Product / Service; Exhibits108: Ottobock SE and Co. KGaA - Key offerings; Exhibits109: SWOT; Exhibits110: Sonova AG - Overview; Exhibits111: Sonova AG - Business segments; Exhibits112: Sonova AG - Key offerings; Exhibits113: Sonova AG - Segment focus; Exhibits114: SWOT; Exhibits115: Terumo Medical Corp. - Overview; Exhibits116: Terumo Medical Corp. - Product / Service; Exhibits117: Terumo Medical Corp. - Key offerings; Exhibits118: SWOT; Exhibits119: Zimmer Biomet Holdings Inc. - Overview; Exhibits120: Zimmer Biomet Holdings Inc. - Business segments; Exhibits121: Zimmer Biomet Holdings Inc. - Key news; Exhibits122: Zimmer Biomet Holdings Inc. - Key offerings; Exhibits123: Zimmer Biomet Holdings Inc. - Segment focus; Exhibits124: SWOT; Exhibits125: Inclusions checklist; Exhibits126: Exclusions checklist; Exhibits127: Currency conversion rates for US$; Exhibits128: Research methodology; Exhibits129: Information sources; Exhibits130: Data validation; Exhibits131: Validation techniques employed for market sizing; Exhibits132: Data synthesis; Exhibits133: 360 degree market analysis; Exhibits134: List of abbreviations